Windtree Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Windtree Therapeutics

31/03/2022 13:51

* Windtree Therapeutics Inc  WINT.OQ  reported a quarterly
adjusted loss of 52 cents​​ per share for the quarter ended in
December. The mean expectation of two analysts for the quarter
was for a loss of 30 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Windtree Therapeutics Inc's reported EPS for the quarter
was a
loss of 52 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Windtree Therapeutics Inc shares had fallen by 27.7% this
quarter.
    * The company reported a quarterly loss of $13.07 million.
    * Wall Street's median 12-month price target for Windtree
Therapeutics Inc is $8.25 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 31 at 12:50 p.m.  ​All
figures in US dollars unless otherwise stated